Get started
Author

Bojan Doljak

Observed names: B. DOLJAK, B. Doljak, Doljak, B., Doljak, Bojan
ORCID: 0009-0005-0741-3830
Observed ORCID: 0009-0005-0741-3830
OpenAlex ID: A5082474963
Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition
2008 · Petra Slanc, Bojan Doljak, et al. · Phytotherapy Research · 145
Cathepsin H Mediates the Processing of Talin and Regulates Migration of Prostate Cancer Cells
2012 · Zala Jevnikar, Matija Rojnik, et al. · Journal of Biological Chemistry · 77
PDF
Role of Cysteine Cathepsins in Matrix Degradation and Cell Signalling
2008 · Nataša Obermajer, Zala Jevnikar, et al. · Connective Tissue Research · 69
Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells
2009 · Nataša Obermajer, Bojan Doljak, et al. · The International Journal of Biochemistry & Cell Biology · 58
Cysteine cathepsins: regulators of antitumour immune response
2006 · Nataša Obermajer, Bojan Doljak, et al. · Expert Opinion on Biological Therapy · 42
Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness
2009 · Nataša Obermajer, Bojan Doljak, et al. · Molecular Cancer · 39
PDF
New biologically active epidioxysterols from Stereum hirsutum
2007 · Francesca Cateni, Bojan Doljak, et al. · Bioorganic & Medicinal Chemistry Letters · 33
Profilin 1 as a Target for Cathepsin X Activity in Tumor Cells
2013 · Urša Pečar Fonović, Zala Jevnikar, et al. · PLoS ONE · 32
PDF
Comparison of Bacterial and Phage Display Peptide Libraries in Search of Target-Binding Motif
2005 · Mojca Lunder, Tomaz Bratkovic, et al. · Applied Biochemistry and Biotechnology · 29
Screening of wood damaging fungi and macrofungi for inhibitors of pancreatic lipase
2004 · Petra Slanc, Bojan Doljak, et al. · Phytotherapy Research · 29
Inactivation of harmful tumour-associated proteolysis by nanoparticulate system
2009 · Janko Kos, Nataša Obermajer, et al. · International Journal of Pharmaceutics · 28
Screening for selective thrombin inhibitors in mushrooms
2001 · B. Doljak, M. Stegnar, et al. · Blood Coagulation & Fibrinolysis · 26
Cathepsin X cleavage of the β2 integrin regulates talin-binding and LFA-1 affinity in T cells
2011 · Zala Jevnikar, Nataša Obermajer, et al. · Journal of Leukocyte Biology · 25
Cathepsin X-mediated β2 integrin activation results in nanotube outgrowth
2009 · N. Obermajer, Z. Jevnikar, et al. · Cellular and Molecular Life Sciences · 22
Identification and characterization of the novel reversible and selective cathepsin X inhibitors
2017 · Urša Pečar Fonović, Ana Mitrović, et al. · Scientific Reports · 21
PDF
Regulation of cathepsin B activity by 2A2 monoclonal antibody
2009 · Bojana Mirković, Aleš Premzl, et al. · FEBS Journal · 17
PDF
Monoclonal antibody to cytokeratin VKIALEVEIATY sequence motif reduces plasminogen activation in breast tumour cells
2008 · Bojan Doljak, Nataša Obermajer, et al. · Cancer Letters · 14
Glycerolipids as Selective Thrombin Inhibitors from the FungusStereum Hirsutum
2006 · Bojan Doljak, Francesca Cateni, et al. · Drug Development and Industrial Pharmacy · 13
A Generic Industry Approach To Demonstrate Efficient Purification of Potential Mutagenic Impurities in the Synthesis of Drug Substances
2015 · Nevenka Lapanja, Borut Zupančič, et al. · Organic Process Research & Development · 12
The influence of differential processing of procathepsin H on its aminopeptidase activity, secretion and subcellular localization in human cell lines
2012 · Matija Rojnik, Zala R. Jevnikar, et al. · European Journal of Cell Biology · 12
Congenital Heart Disease and Genetic Changes in Folate/Methionine Cycles
2024 · Nataša Karas Kuželički, Bojan Doljak · Genes · 11
PDF
Theoretical Purge Factor Determination as a Control Strategy for Potential Mutagenic Impurities in the Synthesis of Drug Substances
2017 · Nevenka Kragelj Lapanja, Renata Toplak Časar, et al. · Acta chimica slovenica · 9
PDF
Evaluation of Starting Materials for PMIs (Potentially Mutagenic Impurities): A Vortioxetine Case Study
2017 · Nevenka Kragelj Lapanja, Borut Zupančič, et al. · Organic Process Research & Development · 8
Triterpenes from Gloeophyllum odoratum as Potential Leads Towards Potent Thrombin Inhibitors
2010 · Francesca Cateni, Vittorio Lucchini, et al. · Letters in Drug Design & Discovery · 8
New Triterpenes from the Fungus Gloeophyllum odoratum
2015 · F. Cateni, V. Lucchini, et al. · Chemistry of Natural Compounds · 5
Works count: 39
Citation count: 786
H-index: 16
I10-index: 21
Year
Topic
Type